Literature DB >> 6496214

The role of trophoblast differentiation in the control of the hCG and hPL genes.

M Hoshina, R Hussa, R Pattillo, H M Camel, I Boime.   

Abstract

Normal trophoblast of the human placenta elaborates at least two major protein hormones, hCG and hPL. Molar and choriocarcinoma tissues characteristically synthesize large amounts of hCG and small quantities of hPL. To examine the role of trophoblast differentiation in the expression of the hCG and hPL genes, we studied the cytological distribution of their mRNAs in tissue sections of human hydatidiform mole and choriocarcinoma by in situ hybridization. Histologically, these tissues are in different stages of cellular differentiation. In normal placenta, hCG alpha and hCG beta mRNAs can be localized to some cytotrophoblasts and primarily to the syncytium, whereas hPL mRNA appears only in the syncytial layer. In hydatidiform mole, which still retains placental villous morphology, the hPL gene and hCG alpha and hCG beta genes are expressed but are poorly localized because of the admixture of cyto- and syncytiotrophoblasts. By contrast, choriocarcinoma, which is devoid of placental villous pattern but in which the cyto- and syncytiotrophoblast-like components are distinguishable, expresses hCG alpha and hCG beta in the syncytial-like areas but little, if any, hPL. These results suggest that a certain level of trophoblast differentiation, such as villus formation, is associated with hPL expression, while the hCG alpha gene and the hCG beta gene can be expressed in more disorganized tissues which contain cytotrophoblastic elements.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496214     DOI: 10.1007/978-1-4684-4811-5_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1.

Authors:  Udo Jeschke; Toralf Reimer; Claudia Bergemann; Irmi Wiest; Sandra Schulze; Klaus Friese; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2004-06-08       Impact factor: 4.304

2.  In-vitro effects of the antimicrobial peptide Ala8,13,18-magainin II amide on isolated human first trimester villous trophoblast cells.

Authors:  Jayasree Sengupta; Meraj Alam Khan; Berthold Huppertz; Debabrata Ghosh
Journal:  Reprod Biol Endocrinol       Date:  2011-04-16       Impact factor: 5.211

3.  Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

Authors:  Miriam Lenhard; Alexandra Tsvilina; Lan Schumacher; Markus Kupka; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

4.  Human Chorionic Gonadotropin Modulates the Transcriptome of the Myometrium and Cervix in Late Gestation.

Authors:  Kenichiro Motomura; Roberto Romero; Jose Galaz; Derek Miller; Bogdan Done; Marcia Arenas-Hernandez; Valeria Garcia-Flores; Li Tao; Adi L Tarca; Nardhy Gomez-Lopez
Journal:  Reprod Sci       Date:  2021-03-01       Impact factor: 2.924

5.  Human Chorionic Gonadotropin Has Anti-Inflammatory Effects at the Maternal-Fetal Interface and Prevents Endotoxin-Induced Preterm Birth, but Causes Dystocia and Fetal Compromise in Mice.

Authors:  Amy-Eunice Furcron; Roberto Romero; Tara N Mial; Amapola Balancio; Bogdan Panaitescu; Sonia S Hassan; Aashna Sahi; Claire Nord; Nardhy Gomez-Lopez
Journal:  Biol Reprod       Date:  2016-05-04       Impact factor: 4.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.